These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15273458)

  • 1. Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block.
    Scaglione J; Socas AG; De Palma C; Kreutzer E
    J Interv Card Electrophysiol; 2004 Aug; 11(1):73-6. PubMed ID: 15273458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
    Schmitt C; Montero M; Melichercik J
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategies in inappropriate ICD therapy].
    Klein G; Korte T
    Herz; 2005 Nov; 30(7):619-24. PubMed ID: 16333588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent inappropriate implantable cardioverter defibrillator therapy was determined to be dual atrioventricular nodal non-reentrant tachycardia: A case report.
    Ma C; Yin X; Xia Y; Li W; Gao L; Dai S; Yu X
    Medicine (Baltimore); 2021 Apr; 100(14):e25370. PubMed ID: 33832121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
    Bayés de Luna A; Oter MC; Guindo J
    Int J Cardiol; 1989 Feb; 22(2):147-50. PubMed ID: 2914739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of radiofrequency ablation of supraventricular tachycardia to decrease inappropriate shocks from implantable cardioverter-defibrillators.
    Mainigi SK; Almuti K; Figueredo VM; Guttenplan NA; Aouthmany A; Smukler J; Sheeron B; Meldrum B; Saenz AD; Tran G; Greenspan AM
    Am J Cardiol; 2012 Jan; 109(2):231-7. PubMed ID: 22000775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.
    Gold MR; Ahmad S; Browne K; Berg KC; Thackeray L; Berger RD
    Heart Rhythm; 2012 Mar; 9(3):370-7. PubMed ID: 21978966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation.
    Corbisiero R; Lee MA; Nabert DR; Coman JA; Breiter DJ; Schwartz M; McKittrick E; Zhang Y
    Europace; 2006 Dec; 8(12):1057-61. PubMed ID: 17105781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator.
    Dorian P; Philippon F; Thibault B; Kimber S; Sterns L; Greene M; Newman D; Gelaznikas R; Barr A;
    Heart Rhythm; 2004 Nov; 1(5):540-7. PubMed ID: 15851216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia: a life-threatening arrhythmia in a patient with congenitally corrected transposition of the great arteries.
    Fontaine JM; Kamal BM; Sokil AB; Wolf NM
    J Cardiovasc Electrophysiol; 1998 May; 9(5):517-22. PubMed ID: 9607461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.
    Hii JT; Gillis AM; Wyse DG; Sheldon RS; Duff HJ; Mitchell LB
    Am J Cardiol; 1993 Mar; 71(7):565-8. PubMed ID: 8438742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.